Certara, Inc.
- CERT
- NASDAQ
- Medical - Healthcare Information Services
- Biosimulation Software
- Drug Development Analytics
$9.37
Today −3.00%Quote Oct 16, 2026, 08:00 PM UTC
+9.21%over the last month
Max drawdown −14.2%From 1-month high −7.0%3 months +35.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.43B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$8.50
−9.3% from here
Floor
$9.30
0.7% below price
Where the price sits
17 analysts
Analyst range, low to high
$7.50$10.00
- Price $9.37
- Resistance $10.02
- Consensus $8.50
The price is just above its floor. Analysts' average target sits about 9% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CERTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Healthcare Information Services
Employees
1,546